PP-002

N/A

Report date: 2024/06/04 16:17:36
NME

Base Information

Drug NamePP-002
Drug Alias NamePP-002PMS-004
ClassificationSmall molecules > Synthetic peptide
Mechanisms of Actionc-Jun N-terminal kinase modulatorsPalmitoyltransferase ZDHHC17 modulators
Targetsc-Jun N-terminal kinasePalmitoyltransferase ZDHHC17
Therapy Area/IndicationsMyocardial InfarctionHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPrimary Peptides Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrimary Peptides IncQingdao Pumeisheng Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionHeart Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A